CO-AX accelerator at Sahlgrenska Science Park invites trailblazing healthtech entrepreneurs for spring 2024 intake
co-ax pressmeddelande

Building on its legacy of fostering impactful healthtech innovations, the CO-AX accelerator at Sahlgrenska Science Park opens its doors for the spring 2024 batch of entrepreneurial talent. This call is directed towards innovators and startups who are leveraging technology to address global health challenges.

Publish date: 2024-01-23 Text: 
Jamie Smith

As a leading accelerator in the healthtech domain, CO-AX offers a unique platform for visionary entrepreneurs to transform their ideas into impactful healthcare solutions. The CO-AX programme is dedicated to nurturing healthtech, medtech, biotech and deeptech startups that are at the forefront of addressing critical health issues, from improving patient care to revolutionizing medical diagnostics.

So far, CO-AX has incubated 140 companies who have raised more than Euros 100 million in capital. 32% of CO-AX portfolio companies operate internationally.

Key benefits for participants

Participants in the CO-AX program will receive comprehensive support, including:

  • Tailored coaching from business advisors, industry experts and mentors
  • Markets access, including test and verification opportunities
  • Roadmap to international growth and access to capital
  • Guidance in regulatory and compliance
  • Exposure to healthcare professionals
  • Events, seminars, co-working offices and shared labs.

Annica Grimberg Lignell, Director Business & Innovation and Head of CO-AX at Sahlgrenska Science Park:
“CO-AX is a perfect place for deeptech, femtech and AI entrepreneurs who want to make a meaningful impact for caregivers. Our healthtech expertise and vast networks help them unlock the full potential of their innovations and to scale faster. Ideal candidates are innovative tech startups that demonstrate a clear vision for addressing unmet needs in global healthcare.”

Pontus Axblom, Co-founder and CEO at Beat Vascular Health:
“We joined CO-AX last year and it has exceeded all our expectations. Everything is geared to help us to grow our business and develop our technology for early detection of cardiovascular disease. The best part is that we get access to a wide range of expertise, but we don’t have to give up a stake in our company to get it. Also, the CO-AX people and parties are legendary!”

Application process and timeline

  • Applications open: 17 January 2024
  • Applications close: 17 March 2024
  • Program start: 23 April 2024

Please visit for detailed information on the application process, program specifics and CO-AX portfolio companies.

About CO-AX
For more information about the CO-AX incubator and accelerator at Sahlgrenska Science Park, please visit

Contact us

Annica Grimberg Lignell

Annica Grimberg Lignell

Director Business & Innovation and Head of CO-AX Accelerator
Manager Startup Accelerator

Related stories